Intellia Therapeutics schedules conference call to discuss Q2 2026 results and business updates

PUBT · 2d ago
Intellia Therapeutics schedules conference call to discuss Q2 2026 results and business updates
  • Intellia scheduled a conference call for Aug. 6, 2026 at 8 a.m. ET to discuss Q2 2026 results, business updates.
  • Webcast access via this link; replay available for about 90 days on intelliatx.com.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellia Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607300800PRIMZONEFULLFEED9799707) on July 30, 2026, and is solely responsible for the information contained therein.